Code of Business Ethics
United under the banner of our corporate philosophy, “Otsuka-people creating new products for better health worldwide”, we are working tirelessly toward a shared vision: improving global health through innovative products and services. As a “Big Venture Company”, we keep moving forward, constantly asking ourselves the following questions: Is our work innovative? Are we meeting the needs of our patients and consumers globally? Do our pharmaceutical products bring something innovative to healthcare? Can our nutraceutical products create new markets?
As we strengthen our presence in the international marketplace, we have a heightened duty to continue fulfilling our ethical and legal obligations as a responsible global corporate citizen. To earn and secure the trust and confidence of our stakeholders including patients and consumers, we operate our business ethically, and with integrity.
The Otsuka Group Global Code of Business Ethics embodies and reiterates our commitment to integrity, which remains steadfast across the Otsuka Group worldwide. I strongly hope that our adherence to the principles set forth in this Code promotes a fair and open workplace inspiring creativity, empowering us to reach our fullest potential, and enabling us to enhance the quality of life worldwide.
July 1, 2014
Tatsuo Higuchi
President and Representative Director, CEO
Meeting Reporting Requirements – Sunshine Act and EFPIA
The Physician Payments Sunshine Act (Sunshine Act) requires Astex to report any transfers of value, including reimbursement of interview-related expenses, to candidates who are US-licensed physicians. Such physicians covered by the Sunshine Act include Doctors of Medicine, Osteopathy, Dentistry, Dental Surgery, Podiatry, Optometry and Chiropractic Medicine licensed to practice medicine in the U.S. On an annual basis, transfers of value information will be submitted to the Centers for Medicare and Medicaid Services (CMS), who will post the submitted data on its public database.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has a Disclosure Code that Astex is committed to follow, as well as any applicable National disclosure requirements. The Code or National requirements may require Astex to report certain transfers of value to Health Care Professionals. If such reporting is required, Astex will make such submissions of information.
As a UK company, Astex is required to comply with the following standards:
Astex Anti-Slavery and Human Trafficking Statement (PDF: 51 kB)
Astex Tax Strategy (PDF: 34 kB)
Astex Use of Experimental Animals (PDF: 35 kb)
© Astex Pharmaceuticals
All rights reserved
